Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

COMPUGROUP MEDICAL DENMARK A/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 3.1% 3.1%   Bankruptcy risk   2.9% 2.9% 2.7% 0.9% 0.8% 0.9% 2.9% 2.9%   Credit score (0-100)   60 60 60 87 93 86 58 58   Credit rating   BBB BBB BBB A AA A BBB BBB   Credit limit (kDKK)   0.0 0.0 0.1 5,259.5 5,766.4 5,895.4 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   60,210 67,230 64,390 73,888 64,851 79,946 0.0 0.0   EBITDA   30,650 34,460 29,760 37,986 30,507 43,560 0.0 0.0   EBIT   30,650 34,460 29,760 35,071 27,562 40,502 0.0 0.0   Pre-tax profit (PTP)   24,650.0 27,700.0 23,380.0 34,935.1 27,537.0 41,043.6 0.0 0.0   Net earnings   24,650.0 27,700.0 23,380.0 27,195.5 21,475.6 32,087.2 0.0 0.0   Pre-tax profit without non-rec. items   30,650 34,460 29,760 34,969 27,537 40,710 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 677 1,005 1,098 0.0 0.0   Shareholders equity total   38,420 41,120 37,504 41,700 36,175 48,262 10,762 10,762   Interest-bearing liabilities   0.0 0.0 0.0 1,944 1,209 1,731 8,250 8,250   Balance sheet total (assets)   55,410 59,260 58,670 56,398 50,908 64,445 19,013 19,013   Net Debt   0.0 0.0 0.0 -10,742 -8,010 -19,017 8,250 8,250     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   60,210 67,230 64,390 73,888 64,851 79,946 0.0 0.0   Gross profit growth   11.1% 11.7% -4.2% 14.8% -12.2% 23.3% -100.0% 0.0%   Employees   54 58 60 66 62 61 0 0   Employee growth %   12.5% 7.4% 3.4% 10.0% -6.1% -1.6% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   55,410 59,260 58,670 56,398 50,908 64,445 19,013 19,013   Balance sheet change%   13.4% 6.9% -1.0% -3.9% -9.7% 26.6% -70.5% 0.0%   Added value   30,650.0 34,460.0 29,760.0 37,986.3 30,477.7 43,560.1 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -13,083 0 0 22,044 -5,252 -5,600 -1,098 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   50.9% 51.3% 46.2% 47.5% 42.5% 50.7% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   58.8% 60.1% 50.5% 61.2% 51.4% 70.6% 0.0% 0.0%   ROI %   64.5% 60.1% 50.5% 67.5% 64.5% 88.3% 0.0% 0.0%   ROE %   66.5% 69.7% 59.5% 68.7% 55.2% 76.0% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   100.0% 100.0% 100.0% 71.4% 67.9% 72.2% 56.6% 56.6%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   0.0% 0.0% 0.0% -28.3% -26.3% -43.7% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 4.7% 3.3% 3.6% 76.7% 76.7%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 24.7% 1.7% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.0 0.0 0.0 2.0 2.0 2.9 0.0 0.0   Current Ratio   0.0 0.0 0.0 2.0 2.0 3.0 0.0 0.0   Cash and cash equivalent   0.0 0.0 0.0 12,685.5 9,218.1 20,747.9 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   0.0 0.0 0.0 13,232.0 12,464.9 26,997.2 -4,125.1 -4,125.1   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   568 594 496 576 492 714 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   568 594 496 576 492 714 0 0   EBIT / employee   568 594 496 531 445 664 0 0   Net earnings / employee   456 478 390 412 346 526 0 0